Gender Selection in North Cyprus: Laws, Process, Costs & Success Rates
The Legal Framework: Why North Cyprus Allows Gender Selection
Gender selection for family balancing is one of the most sought-after fertility services that draws international patients to North Cyprus. While countries across the European Union, the United Kingdom, Australia, and Canada have banned non-medical sex selection, North Cyprus permits gender selection through PGT-A (Preimplantation Genetic Testing for Aneuploidies) as part of IVF treatment. This legal distinction has made the island a global hub for families seeking to choose the sex of their child.
The legal framework in North Cyprus does not impose restrictions on the reasons for which patients may request PGT-A. Whether the motivation is family balancing — for example, a couple with three sons who wish for a daughter — or cultural and personal preferences, clinics are permitted to disclose and select based on embryo sex. This openness, combined with the island's established IVF treatment infrastructure, creates a welcoming environment for patients from restrictive jurisdictions. For a complete overview of fertility laws, see our PGD/PGT guide.
How PGT-A Gender Selection Works
The IVF and Testing Process
Gender selection in North Cyprus is not a standalone procedure — it is performed as part of a full IVF cycle. The process follows these steps:
Step 1: Ovarian stimulation. The female partner takes injectable hormones for 10-12 days to stimulate multiple egg production. Regular ultrasound monitoring tracks follicle growth at one of the clinics in North Cyprus.
Step 2: Egg retrieval and fertilization. Mature eggs are collected under light sedation and fertilized using ICSI to maximize fertilization rates.
Step 3: Embryo culture to blastocyst. Embryos are cultured in the laboratory for 5-6 days until they reach the blastocyst stage, when a biopsy can be safely performed.
Step 4: Trophectoderm biopsy and PGT-A. A small number of cells are carefully removed from the outer layer of each embryo and sent for genetic analysis. The test examines all 23 pairs of chromosomes, determining both the chromosomal health of the embryo and its sex (XX for female, XY for male).
Step 5: Embryo selection and transfer. Once results are available (typically within 7-14 days), the patient and doctor select a chromosomally normal embryo of the desired sex for transfer. Remaining healthy embryos can be vitrified for future use.
Accuracy and Reliability
The accuracy of gender determination through PGT/PGD is 99.9%. Unlike older methods such as sperm sorting (which offered only 70-80% accuracy), PGT-A provides near-absolute certainty because it directly analyses the chromosomal makeup of each embryo. This makes it the most reliable method of sex selection available in modern reproductive medicine.
Cost Breakdown for Gender Selection
The cost of gender selection in North Cyprus comprises two main components: the IVF cycle itself and the PGT-A testing. Here is a typical breakdown:
IVF/ICSI cycle: €2,800 - €3,800. This covers consultations, monitoring, egg retrieval, ICSI fertilization, embryo culture, and transfer.
PGT-A testing: €3,000 - €4,000 for up to 8 embryos. Some clinics charge a per-embryo fee if you have more than 8 blastocysts.
Total cost for gender selection: €5,800 - €7,800. This represents a fraction of what patients would pay in countries where it is legal, such as the United States, where gender selection IVF cycles commonly exceed $20,000.
Additional costs to consider include fertility medications (€400-€800), accommodation for 10-14 days, and flights to Ercan Airport. Even with these additions, the total rarely exceeds €9,000-€10,000 all-inclusive.
Who Chooses Gender Selection?
Patients who seek gender selection in North Cyprus come from diverse backgrounds and for various reasons:
Family balancing is the most common motivation. Couples who already have children of one sex and wish to have a child of the other sex represent the majority of gender selection patients. Many come from the UK, Germany, Scandinavia, and the Middle East.
Cultural preferences also drive demand, particularly among families from South Asian and Middle Eastern backgrounds where family composition carries cultural significance.
Medical indications exist as well. Some genetic disorders are sex-linked, meaning they predominantly affect one sex. In these cases, gender selection serves a clear medical purpose, screening out embryos that would carry the condition.
Ethical Considerations
Gender selection is a topic that generates significant ethical debate. North Cyprus clinics approach it with professionalism and sensitivity. Most reputable clinics ensure that patients receive thorough counselling before proceeding, that the primary benefit of PGT-A — screening for chromosomal abnormalities — is explained alongside gender identification, and that patients understand all embryos of the non-desired sex can be safely frozen for future family building.
It is worth noting that PGT-A serves a dual purpose: it simultaneously improves IVF success rates by identifying chromosomally healthy embryos and enables gender identification. Many patients who initially seek gender selection also benefit from the improved pregnancy rates and reduced miscarriage risk that come with transferring only euploid embryos.
Choosing a Clinic for Gender Selection
When selecting a clinic for gender selection in North Cyprus, consider the following factors: the laboratory's experience with trophectoderm biopsy and PGT-A, turnaround time for genetic results, the clinic's blastocyst culture rate, and transparent pricing without hidden fees.
Browse verified clinics in North Cyprus that offer PGT-A services, or connect with experienced consultants who specialise in guiding patients through the gender selection process. With the right clinic and clear communication, gender selection in North Cyprus offers families a reliable, affordable, and legally supported path to achieving their desired family composition.
